- Time is Running Out for the Future of Game of ThronesPosted 7 days ago
- HBO Grants Game of Thrones Epic Season 4Posted 77 days ago
- Dispute Gets Game of Thrones Actor The Tyson VS Holyfield TreatmentPosted 83 days ago
- Game of Thrones: George R. R. Martin Makes a Cameo in Season 4Posted 87 days ago
- Jon Snow & Ygritte Get Cozy In Game of Thrones Portraits!Posted 89 days ago
- Watch The Newest Game of Thrones Trailer!Posted 91 days ago
- Game of Thrones Season 3 is a Beast Waiting to be StirredPosted 92 days ago
- Game of Thrones Recap: Get Caught Up On Season 2Posted 99 days ago
- Game of Thrones Extended Season 3 Trailer Has Bears, Sex, Flaming Swords and Everything ElsePosted 106 days ago
- Game of Thrones: Shadowed Cast in New Season 3 PostersPosted 107 days ago
The Side Effects Include Blake Lively
Refusing to let Green Lantern drag her down, Blake Lively is set to join Steven Soderbergh’s The Side Effects, and she’s not the only big name that will round out the cast for the psychological thriller.
The Side Effects, formerly known as The Bitter Pill, will star Lively as Emily Hawkins, a woman who turns to prescription drugs to handle the anxiety of her husband’s upcoming release from prison. Channing Tatum, who worked with Soderbergh on Haywire and Magic Mike, is being looked at for the role of the husband, while Jude Law, who worked with Soderbergh on Contagion, is being considered for the role of Lively’s new psychiatrist. No deals are currently done with any of the three actors, but IndieWire indicates that deals with the trio are imminent.
One minor bump on the road toward production for The Side Effects is the fact that financial backing is a little questionable at the moment. Summit was originally going to take care of the financing but that’s no longer the case, possibly because Summit is in the process of being bought by Lionsgate. Annapurna Pictures will reportedly step in to handle financial matters, but that’s another deal that hasn’t actually been committed to.Of course, there’s also the matter of distribution to be dealt with but that probably won’t be a problem if everything else goes as planned.